Roelke Alison Marie

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Roelke Alison Marie's trades of Standard BioTools Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Somalogic Inc (SLGC)
Transaction date
Sale
Price
2.43
Quantity 5,675 -24.9%
Value US$13,791
US Somalogic Inc (SLGC)
Transaction date
Sale
Price
2.33
Quantity 3,434 -36.1%
Value US$8,001
Transaction date
Sale
Price
78.08
Quantity 1,097 -29.7%
Value US$85,648
Transaction date
Sale
Price
115.00
Quantity 1,100 -27.2%
Value US$126,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-24 2024-06-24
PrS Proposed sale
98,182
31.01
US$4,292,166 		98,182 31.01 US$4,292,166
2024-06-24 2024-06-24
PrS Proposed sale
53,397
412.19
US$804,031 		53,397 412.19 US$804,031
2024-04-04 2024-04-04
PrS Proposed sale
97,768
224.72
US$1,209,802 		97,768 224.72 US$1,209,802
2023-11-14 2023-11-10
US Somalogic Inc (SLGC)
S Sale
5,675 -24.9%
2.43
US$13,791 		5,675 -24.9% 2.43 US$13,791
2023-10-02 2023-09-15
US Somalogic Inc (SLGC)
S Sale
3,434 -36.1%
2.33
US$8,001 		3,434 -36.1% 2.33 US$8,001
2022-03-14 2022-03-10
S Sale
1,097 -29.7%
78.08
US$85,648 		1,097 -29.7% 78.08 US$85,648
2021-03-29 2021-03-25
S Sale
1,100 -27.2%
115.00
US$126,500 		1,100 -27.2% 115.00 US$126,500